HOME /

About

Haobo Li, PhD

 

Contact

Room 3400, 185 Cambridge Street, Boston, MA 02114. Tel: 1-617-800-7960. Email: haobo.li [AT] mgh.harvard.edu

Academic Appointment

2019- Instructor in Medicine, Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School

2017-2019 Research Fellow, Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School

Education

The University of Hong Kong (PhD, Advisor: Dr. ZY Xia and Prof. MG Irwin); South China Agricultural University (MSc, Advisor: Prof. XB Wen and Bsc, Advisor: Prof. JY Ma)

Hornor

AHA Career Development Award (2020-2023); Melvin L. Marcus Early Career Investigator Award Finalist (2020); BCVS Abstract Travel Award (2019); Faculty Research Output Award (2018); AHA Postdoctoral Fellowship (2017-2019); Fellow of Global Young Scientists Summit (2016); YS and Christabel Lung Postgraduate Scholarship (2015); Graduate Student Scientist Award (2015)...

Professional Service

Member: American Heart Association (2014-); American Society for Pharmacology & Experimental Therapeutics (2013-); International Society of Heart Research (2016-); International Anesthesia Research Society (2014-); American Diabetes Association (2018-).

Reviewer: JACC; JAMA Surg; Ann Intern Med; Cell Death Dis; Br J Pharmacol; JAHA; BBA Mol Basis Dis; Br J Anaesth; Clin Sci; Aging-US; Sci Rep; PLoS One; J Cell Mol Med; Oxid Med Cell Longev; Front Physiol; Cell Physiol Biochem; Appl Physiol Nutr Metab; Am J Physiol Heart Circ Physiol;Am J Physiol Cell Physiol; J Appl Physiol; Neuroscience; J Biochem Mol Toxicol; Biochem J; Biomed Pharmacother; J Diabetes Res; Horm Metab Res; J Therm Biol; J Diabetes; Physiol Genomics; Gene; Eur J Pharmacol; Biosci Rep; Neural Regen Res; Biomed Rep; J Biochem Mol Toxicol; Mol Med Rep; Br J Med Med Res.

Editor: Oxid Med Cell Longev (Leading guest editor, 2017, 2018); Int J Mol Sci (Guest editor, 2017)

Grant reviewer: Swiss National Science Foundation (2015-2019)

Selected Publication

  1. Li H, Hastings M, Rhee J, Trager L, Roh J, Rosenzweig A. Targeting age-related pathways in heart failure. Circ Res. 2020,126:533-51

  2. Li H, Yao W, Liu Z, Xu A, Huang Y, Ma XL, Irwin MG, Xia Z. Hyperglycemia abrogates ischemic postconditioning cardioprotection by impairing AdipoR1/Caveolin-3/STAT3 signaling in Diabetic Rats. Diabetes 2016, 65(4):942-55. (Published with an commontary)

  3. Li H, Yao W, Irwin MG, Wang T, Wang S, Zhang L, Xia Z. Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1. Free Radic Biol Med 2015, 84:311-21.

  4. Li H, Liu Z, Wang J, Wong GT, Cheung CW, Zhang L, Chen C, Xia Z, Irwin MG. Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats. Cardiovasc Diabetol 2013, 12,133. (Highly accessed)

Full list of publication on pubmed: https://www.ncbi.nlm.nih.gov/myncbi/haobo.li.1/bibliography/54248051/public/